Market Place
Sourcing Support
UNITY Biotechnology Reveals ASPIRE Phase 2b Study Results
24 Mar 2025 //
GLOBENEWSWIRE
UNITY Biotechnology to Host Virtual Investor Event on March 24
23 Mar 2025 //
GLOBENEWSWIRE
Unity Biotech Adds Ophthalmology Expert Yehia Hashad To Board
10 Mar 2025 //
GLOBENEWSWIRE
UNITY Biotechnology Reports Q4 and Full Year 2024 Results
07 Mar 2025 //
GLOBENEWSWIRE
UNITY Biotech Reports Granting of New Employment Inducement Award
07 Jan 2025 //
GLOBENEWSWIRE
UNITY Biotech Announces Appointment of Federico CMO
06 Jan 2025 //
GLOBENEWSWIRE
UNITY Biotechnology Reports Q3 2024 Results and Business Updates
04 Nov 2024 //
GLOBENEWSWIRE
UNITY Biotechnology Hosts In-Person Ophthalmology Day
24 Sep 2024 //
GLOBENEWSWIRE
UNITY Biotechnology to Participate in Upcoming Investor Conferences
12 Aug 2024 //
GLOBENEWSWIRE
UNITY Biotech Reports Q2 2024 Results And Business Updates
06 Aug 2024 //
GLOBENEWSWIRE
UNITY Biotechnology Reports Granting of New Employment Inducement Award
24 Jul 2024 //
GLOBENEWSWIRE
UNITY Biotechnology Names Alicia Tozier As Chief Strategy Officer
22 Jul 2024 //
GLOBENEWSWIRE
UNITY Biotechnology Reports Q1 2024 Results, Business Updates
14 May 2024 //
GLOBENEWSWIRE
UNITY Presents at ARVO 2024 Annual Meeting
25 Apr 2024 //
GLOBENEWSWIRE
UNITY Extends Phase 2b ASPIRE Testing UBX1325 In Diabetic Macular Edema
23 Apr 2024 //
GLOBENEWSWIRE
UNITY Bio Q4 & FY2023 Results, Business Update
15 Apr 2024 //
GLOBENEWSWIRE
New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics
06 Feb 2024 //
GLOBENEWSWIRE
UNITY Bio Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME
12 Dec 2023 //
GLOBENEWSWIRE
UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
UNITY Bio Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
10 Nov 2023 //
GLOBENEWSWIRE
UNITY Bio Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325
27 Sep 2023 //
GLOBENEWSWIRE
After wet AMD trial, Unity gathers around diabetic macular edema
27 Sep 2023 //
FIERCE BIOTECH
Unity’s Phase II wet AMD therapy trial concludes subject enrolment
20 Sep 2022 //
CLINICALTRIALS ARENA
UNITY Biotechnology Announces Positive Data in Ph2 BEHOLD of UBX1325
12 Aug 2022 //
GLOBENEWSWIRE
Unity finds itself with a finite amount of cash new data provide a ray of hope
12 Aug 2022 //
ENDPTS
Unity Biotechnology Announces Addn Data From Phase 1 Study Of UBX1325
14 Feb 2022 //
PRESS RELEASE
No unity here: Unity slashes half of staff to focus on eye drug
04 Feb 2022 //
FIERCEBIOTECH
UNITY reports positive Phase I data of vascular eye disease drug
06 Oct 2021 //
CLINICALTRIALSARENA
Can a rare immune cell offer the key to slowing down senescence? A Bay Area
11 May 2021 //
ENDPTS
Bob Nelsen exits board and president steps down at Unity as fallout
16 Dec 2020 //
ENDPTS
A month after losing its lead program, Unity Biotechnology cuts 30% of staff
15 Sep 2020 //
ENDPOINTS
UNITY Biotechnology Announces Actions to Focus on Senolytic Programs
15 Sep 2020 //
GLOBENEWSWIRE
Unity’s Phase II osteoarthritis study of UBX0101 misses primary goal
18 Aug 2020 //
CLINICALTRIALSARENA
In blow to anti-aging field, Unity Biotechnology fails first major study
18 Aug 2020 //
ENDPTS
Unity Biotechnology fails early test, raising doubts ability to develop drugs
17 Aug 2020 //
STATNEWS
Buzzy anti-aging biotech Unity drops leading program
17 Aug 2020 //
FIERCEBIOTECH
UNITY Biotechnology Announces CFO Transition
06 Jul 2020 //
GLOBENEWSWIRE
UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101
01 Apr 2020 //
GLOBENEWSWIRE
Biogen`s early R&D chief Ghosh leaves to take Unity CEO post
03 Mar 2020 //
FIERCE BIOTECH
Unity`s early longevity data look `encouraging`
18 Jun 2019 //
ENDPTS
Stopping cancer before it develops
05 Jun 2019 //
FIERCE BIOTECH
UNITY Biotechnology, Inc. & UCSF Enter Agreement on alpha-Klotho Protein
29 May 2019 //
SEEKINGALPHA
